Table 1.

Demographic, laboratory, and symptom data for persons with eosinophilic meningitis attributable to infection with Angiostrongylus cantonensis in Hawaii from January 2003 to April 2005 (N = 18)

Patient no.	Age (years)	Sex	Days between symptom onset and LP	CSF indices					Peripheral blood indices		Initial symptom(s)	Duration of headache (days)	Duration of sensory symptoms (days)
				WBC (cells/mm3)	RBC (cells/mm3)	% Eo	Glu (mg/dL)	Prot (mg/dL)	WBC (cells/mm3) × 1,000	% Eo
Median	32	–	7	637	7	33	46.5	110	10.3	10	–	–	–
1	0.9	F	6	442	1,629	67	52	–	16	16	Fever	UNK	UNK
2	17	M	7	1,583	0	74	37	94	7.8	19	Headache	21	NA
3	18	M	23	910	9	54	35	76	11.8	10	Myalgia and fatigue	42	28
4	21	F	2	419	5	6	63	54	–	–	Headache	310*	NA
5	22	M	3	424	56	7	67	108	11.6	0	Headache and fever	10	10
6	25	M	7	690	735	42	54	43	5.9	4	Myalgia	7	NA
7	29	M	15	513	1	51	–	–	9.5†	7	Chest pain	18	50*
8	31	M	8	344	1	52	51	60	8.2	16	Paresthesia	21	14
9	31	F	12	129	4	16	32	227	7.2	9	Hyperesthesia	7	90
10	32	M	1	684	46	11	51	119	8.3	3	Headache	44*	NA
11	34	F	1	703	–	4	70	56	10.3‡	16	Headache	70*	5
12	35	F	14	8,168	1	60	39	165	8.8	3	Headache	14	NA
13	35	M	3	843	6	14	26	110	8	7	Headache	3	NA
14	35	F	11	860	2	23	26	110	16.7‡	4	Lethargy	7	82*
15	35	M	7	330	–	20	–	–	20.3	24	Abdominal pain	2	18*
16	42	M	48	1,425	203	12	28	215	12.1‡	20	Paresthesia	NA	129*
17	43	M	1	373	14	47	36	186	15.9	8	Headache	UNK	UNK
18	46	F	12	590	8	43	48	153	14	27	Paresthesia	14	150*

WBC = white blood cell count; RBC = red blood cell count; Eo = eosinophil; Glu = glucose; Prot = protein; NA = not applicable; UNK = unknown.

^*Symptom still present at time of interview.

^†Peripheral blood WBC and eosinophil percent were not available on the same day: WBC was from day 3, and eosinophil percent was from day 2.

^‡Peripheral blood results were not from the same day as CSF results. Reported results were from closest day to LP.